 BOCA RATON, Fla.--BUSINESS WIRE--TherapeuticsMD, Inc. NASDAQ: TXMD, an innovative, leading womens healthcare company, today announced the appointment of Mark Glickman as the Companys Chief Business Officer. Mr. Glickman previously served as Chief Commercial Officer of Esperion and Aralez Pharmaceuticals, and Executive Vice President, Sales and Marketing, of Auxilium Pharmaceuticals, among other global pharmaceutical roles. Mr. Glickman received his MBA in Finance and International Managem 